Immunogenicity and Safety of SpikoGen, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein, as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-arm Clinical Trial

PURPOSE: Studies have found that immunocompromised patients have suboptimal responses to COVID-19 vaccines, leading to approval of a need for booster doses in this population. SpikoGen® is a subunit recombinant spike protein vaccine combined with Advax-CpG55.2™ adjuvant to protect against COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales: Nafar, Mohsen, Mostafaloo, Narges, Firouzan, Ahmad, Poorrezagholi, Fatemeh, Samadian, Fariba, Dalili, Nooshin, Barati, Saghar, Anjidani, Nassim, Kafi, Hamidreza, Shahpari, Ramin, Bayat, Mahdiye, Kianipour, Soha, Samavat, Shiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595368/
https://www.ncbi.nlm.nih.gov/pubmed/36402595
http://dx.doi.org/10.1016/j.clinthera.2022.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595368/
https://www.ncbi.nlm.nih.gov/pubmed/36402595
http://dx.doi.org/10.1016/j.clinthera.2022.10.002

Ejemplares similares